Kenvue (KVUE) gets examined here through its financial statements, valuation metrics, and capital allocation track record.
Revenue Trend
On the revenue front, the picture isn't encouraging: Kenvue posted $15.12B in FY2025, a 2.1% decline from FY2024 levels.
Over the past 5 years, revenue has compounded at just 0.9% annually, moving from $14.47B to $15.12B. That pace barely clears inflation.
With $15.12B in annual revenue, Kenvue sits in mid-cap territory within the consumer staples space.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | $15.12B | -2.1% |
| FY2024 | $15.46B | +0.1% |
| FY2023 | $15.44B | +3.3% |
| FY2022 | $14.95B | -0.7% |
| FY2021 | $15.05B | +4.1% |
View the detailed revenue trend and growth analysis
Revenue by Segment
Kenvue breaks its revenue across 3 product segments. The FY2025 split is shown below.
Revenue by Product Segment (FY2025)
| Segment | Revenue | % of Total |
|---|---|---|
| Self Care | $6.38B | 42.2% |
| Essential Health | $4.63B | 30.6% |
| Skin Health and Beauty | $4.11B | 27.2% |
Self Care is Kenvue's clear revenue leader, accounting for 42.2% of total sales.
Geographically, revenue is spread across North America (48%), EMEA (25%), Asia Pacific (18%), and Latin America (9%).
Kenvue Earnings & Margins
Net income jumped 42.7% year-over-year in FY2025, climbing from $1.03B to $1.47B.
The net profit margin widened to 9.7% in FY2025 from 6.7% in FY2024, reflecting improved cost discipline.
Diluted EPS came in at $0.76 for FY2025, up from $0.54 in the prior year.
Explore the profitability trend in detail below
Dividends & Shareholder Returns
Kenvue paid out $0.82 per share in dividends in FY2025, translating to a yield of roughly 4.53%.
A payout ratio of 108.1% leaves little cushion at Kenvue. Any softness in earnings could put the dividend under pressure.
| Year | DPS | Payout Ratio |
|---|---|---|
| FY2025 | $0.82 | 108.1% |
| FY2024 | $0.81 | 149.5% |
| FY2023 | $7.60 | 873.5% |
Over the past 2 years, Kenvue has put $432.0M to work buying back its own shares.
View the full share repurchase and dilution trend
Kenvue's Balance Sheet Health
| Metric | Value |
|---|---|
| Cash & Short-term Investments | $1.06B |
| Total Debt | $8.52B |
| Shareholders' Equity | $10.77B |
| Total Assets | $27.08B |
| Debt-to-Equity Ratio | 0.79x |
| Current Ratio | 0.96x |
| Interest Coverage | 7.1x |
| Free Cash Flow (TTM) | $1.72B |
A debt-to-equity ratio of 0.79, a current ratio of 0.96, and interest coverage of 7.1x in FY2025 together point to a well-capitalized balance sheet carrying manageable debt.
Kenvue carries $8.52B in debt against $1.06B in cash, and its 0.79x D/E ratio confirms the balance sheet remains adequately capitalized.
Interest coverage sits at 7.1x, meaning Kenvue's operating income covers its interest obligations with room to spare.
Free cash flow of $1.72B gives Kenvue solid capacity to fund dividends, buybacks, and debt reduction simultaneously.
See the detailed financial health breakdown in the charts
Kenvue's FY2025 headcount stood at 22,000, putting revenue per employee at roughly $687.5K.
See Kenvue's full employee count history and revenue per employee
Valuation Check: Is Kenvue Overpriced?
So is Kenvue stock overvalued or undervalued? The valuation models below offer some perspective.
Kenvue shares are currently trading at $19.01.
Applying the P/E Ratio model produces a fair value of $18 for Kenvue.
Intrinsic value is also estimated using the DCF and EPS Growth models. Sign up to see the full breakdown with fair value estimates.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | $18 | 8.1% downside to fair value |
| DCF | Upgrade | Upgrade |
| EPS Growth | Upgrade | Upgrade |
Key Highlights
Pulling back to survey Kenvue's overall financial position: the data offers a fairly clear picture for anyone evaluating this consumer staples stock.
FY2025 revenue of $15.12B, down 2.1% from the prior year.
Over a 5-year horizon, revenue has compounded at 0.9% per year.
Profitability is solid, with a net margin of 9.7% and net income of $1.47B.
Capital returned to shareholders totaled $1.78B in FY2025 via dividends and/or buybacks.
The balance sheet is conservative, carrying a D/E ratio of 0.79x.
The P/E Ratio model implies 8.1% downside to fair value. The remaining 2 models are worth cross-checking before drawing a conclusion. Sign up to see the full analysis.
The charts below contain Kenvue's complete financial data, including valuation models and historical trends.